COSIRA trial

Related by string. * Cosira : / trialed . trialing . trials . Trials . TRIAL . Trial . TRIALS . trialer . Trialing : Phase III clinical trials . Week Premium Trial . Phase III trials . placebo controlled clinical trials . randomized controlled trial . randomized controlled trials . trial . Phase III Clinical Trial . Trial Lawyers Association . Phase IIa clinical trials . randomized clinical trials * *

Related by context. Frequent words. (Click for all words.) 64 Phase Ib clinical 63 Phase III Clinical Trial 63 phase IIa 62 Phase III pivotal 62 Phase Ib 62 registrational 61 Phase 2a trial 61 Phase 2b trial 61 confirmatory Phase III 61 Phase 2a 61 Phase 1b 60 Phase 2a clinical 60 Pivotal Phase III 60 Pivotal Phase 60 Phase 1b trial 60 Stedivaze 60 Phase 2b clinical 60 multicenter clinical 60 registrational trial 60 double blinded placebo 59 Pivotal Trial 59 R sorafenib tablets 59 Phase 2b study 59 MOZOBIL 59 Investigational Device Exemption IDE 59 CR# vcMMAE 59 placebo controlled clinical 58 Cethrin 58 phase IIb 58 Phase IIa trial 58 Omigard 58 Pulmonary Arterial Hypertension 58 Phase IIa clinical trials 58 Hepatitis C HCV 58 placebo controlled Phase 58 deforolimus 58 relapsed refractory multiple myeloma 58 PXD# 58 RRMS patients 58 confirmatory Phase 3 57 ALN TTR# 57 pivotal Phase III 57 pharmacodynamic effects 57 Phase IIb clinical 57 Cloretazine R VNP#M 57 prospective observational 57 PROPEL trial 57 isavuconazole 57 Phase 1b clinical 57 Phase 2b 57 Phase IIb 57 elotuzumab 57 Investigational Device Exemption 57 IND enabling 57 MEK inhibitor 57 IND submission 56 Azedra 56 unblinding 56 superficial bladder cancer 56 Phase Ia 56 ATL# [001] 56 Phase III 56 Phase III clinical 56 squalamine 56 ponatinib 56 MONOVISC 56 Patient Enrollment 56 IoGen 56 dose escalation 56 Metastatic Melanoma 56 Phenoptin 56 GLPG# 56 PROMACTA 56 AGGRASTAT ® 56 Phase IIb trial 56 prospective multicenter 56 phase 2a 56 Virulizin R 56 StemEx 56 exemption IDE 56 KRN# 56 PRECiSE 56 multiple ascending dose 56 blinded placebo controlled 56 CCX# 55 Cethromycin 55 Icatibant 55 BAY #-# 55 Sym# 55 ISTODAX 55 BLA submission 55 NEBIDO 55 Phase IIa clinical 55 tesmilifene 55 dose escalation trial 55 Phase III Trial 55 PREVAIL 55 Phase IIa 55 Amrubicin 55 placebo controlled randomized 55 Traficet EN

Back to home page